DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Talampanel

Talampanel

  • Stems for Nonproprietary Drug Names

    Stems for Nonproprietary Drug Names

  • (12) United States Patent (10) Patent No.: US 9.402,830 B2 Cialella Et Al

    (12) United States Patent (10) Patent No.: US 9.402,830 B2 Cialella Et Al

  • UNDERSTANDING PHARMACOLOGY of ANTIEPILEPTIC DRUGS: Content

    UNDERSTANDING PHARMACOLOGY of ANTIEPILEPTIC DRUGS: Content

  • Whole Document

    Whole Document

  • Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures

    Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures

  • Dual Variable Domain Immunoglobulins and Uses Thereof

    Dual Variable Domain Immunoglobulins and Uses Thereof

  • Discovery of New AMPA Antagonist, Perampanel, Implication of Role in Seizure Disorders

    Discovery of New AMPA Antagonist, Perampanel, Implication of Role in Seizure Disorders

  • Neurochemical and Behavioral Features in Genetic Absence Epilepsy and in Acutely Induced Absence Seizures

    Neurochemical and Behavioral Features in Genetic Absence Epilepsy and in Acutely Induced Absence Seizures

  • General Pharmacology

    General Pharmacology

  • Deficiency of Cyclin-Dependent Kinase-Like 5 Causes Spontaneous Epileptic Seizures in Neonatal Mice

    Deficiency of Cyclin-Dependent Kinase-Like 5 Causes Spontaneous Epileptic Seizures in Neonatal Mice

  • 193 Nitric Oxide, a New Player in L-Dopa-Induced Dyskinesia? Elaine

    193 Nitric Oxide, a New Player in L-Dopa-Induced Dyskinesia? Elaine

  • Propanenitrile Derivatives As Orally Active AMPA Receptor Antagonists

    Propanenitrile Derivatives As Orally Active AMPA Receptor Antagonists

  • Development of an Experimentally Useful Model of Acute Myocardial Infarction: 2/3 Nephrectomized Triple Nitric Oxide Synthases-Deficient Mouse

    Development of an Experimentally Useful Model of Acute Myocardial Infarction: 2/3 Nephrectomized Triple Nitric Oxide Synthases-Deficient Mouse

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Green Chemistry CHM 459

    Green Chemistry CHM 459

  • The Evolution of Antiepileptic Drug Development and Regulation

    The Evolution of Antiepileptic Drug Development and Regulation

  • Protection from Fatal Viral Encephalomyelitis: AMPA Receptor Antagonists Have a Direct Effect on the Inflammatory Response to Infection

    Protection from Fatal Viral Encephalomyelitis: AMPA Receptor Antagonists Have a Direct Effect on the Inflammatory Response to Infection

  • Download Product Insert (PDF)

    Download Product Insert (PDF)

Top View
  • Effect of Caffeine Contained in a Cup of Coffee on Microvascular Function In
  • The Effects of Aniracetam Treatment on Cognitive Performance and AMPA Receptor Glur2 Subunit Expression After Moderate Fluid Percussion Injury in Rats
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Forskning På Amyotrofisk Lateralsklerose. Litteratursøk. English Title Research on Amyotrophic Lateral Sclerosis
  • Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
  • ( 12 ) United States Patent
  • Innovations in Epilepsy Management – an Overview
  • Influence of the N-Acetylation Polymorphism on the Metabolism of Talampanel: an Investigation in Fasted and Fed Subjects Genotyped for NAT2 Variants
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0000815 A1 BIRD (43) Pub
  • (12) United States Patent (10) Patent No.: US 7,612,181 B2 Wu Et Al
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Customs Tariff - Schedule Xxi - 1
  • Appendix E-3: Complete Search Strategy
  • Convergent Functional Genomic Studies of Omega-3 Fatty Acids in Stress Reactivity, Bipolar Disorder and Alcoholism
  • WO 2U11/132171 Al
  • Neuro-Oncology
  • Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances


© 2024 Docslib.org    Feedback